UniProt ID | SFR15_HUMAN | |
---|---|---|
UniProt AC | O95104 | |
Protein Name | Splicing factor, arginine/serine-rich 15 | |
Gene Name | SCAF4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1147 | |
Subcellular Localization | Nucleus. | |
Protein Description | May act to physically and functionally link transcription and pre-mRNA processing.. | |
Protein Sequence | MDAVNAFNQELFSLMDMKPPISRAKMILITKAAIKAIKLYKHVVQIVEKFIKKCKPEYKVPGLYVIDSIVRQSRHQFGTDKDVFGPRFSKNITATFQYLYLCPSEDKSKIVRVLNLWQKNGVFKIEIIQPLLDMAAGTSNAAPVAENVTNNEGSPPPPVKVSSEPPTQATPNSVPAVPQLPSSDAFAAVAQLFQTTQGQQLQQILQTFQQPPKPQSPALDNAVMAQVQAITAQLKTTPTQPSEQKAAFPPPEQKTAFDKKLLDRFDYDDEPEAVEESKKEDTTAVTTTAPAAAVPPAPTATVPAAAAPAAASPPPPQAPFGFPGDGMQQPAYTQHQNMDQFQPRMMGIQQDPMHHQVPLPPNGQMPGFGLLPTPPFPPMAQPVIPPTPPVQQPFQASFQAQNEPLTQKPHQQEMEVEQPCIQEVKRHMSDNRKSRSRSASRSPKRRRSRSGSRSRRSRHRRSRSRSRDRRRHSPRSRSQERRDREKERERRQKGLPQVKPETASVCSTTLWVGQLDKRTTQQDVASLLEEFGPIESINMIPPRGCAYIVMVHRQDAYRALQKLSRGNYKVNQKSIKIAWALNKGIKADYKQYWDVELGVTYIPWDKVKPEELESFCEGGMLDSDTLNPDWKGIPKKPENEVAQNGGAETSHTEPVSPIPKPLPVPVPPIPVPAPITVPPPQVPPHQPGPPVVGALQPPAFTPPLGIPPPGFGPGVPPPPPPPPFLRPGFNPMHLPPGFLPPGPPPPITPPVSIPPPHTPPISIPNSTIAGINEDTTKDLSIGNPIPTVVSGARGNAESGDSVKMYGSAVPPAAPTNLPTPPVTQPVSLLGTQGVAPGPVIGLQAPSTGLLGARPGLIPLQRPPGMPPPHLQRFPLMPPRPMPPHMMHRGPPPGPGGFAMPPPHGMKGPFPPHGPFVRPGGMPGLGGPGPGPGGPEDRDGRQQPPQQPQQQPQPQAPQQPQQQQQQQPPPSQQPPPTQQQPQQFRNDNRQQFNSGRDQERFGRRSFGNRVENDRERYGNRNDDRDNSNRDRREWGRRSPDRDRHRDLEERNRRSSGHRDRERDSRDRESRREKEEARGKEKPEVTDRAGGNKTVEPPISQVGNVDTASELEKGVSEAAVLKPSEELPAEATSSVEPEKDSGSAAEAPR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
41 | Acetylation | IKAIKLYKHVVQIVE HHHHHHHHHHHHHHH | 40.12 | 26051181 | |
104 | Ubiquitination | QYLYLCPSEDKSKIV EEEEECCCCCHHHHH | 58.38 | 21890473 | |
119 | Acetylation | RVLNLWQKNGVFKIE HHHHHHHHCCEEEEE | 44.05 | 25953088 | |
119 (in isoform 1) | Ubiquitination | - | 44.05 | 21890473 | |
119 (in isoform 2) | Ubiquitination | - | 44.05 | 21890473 | |
517 | Acetylation | LWVGQLDKRTTQQDV EEEECCCCCCCHHHH | 61.30 | 26051181 | |
562 | Acetylation | DAYRALQKLSRGNYK HHHHHHHHHHCCCCC | 49.64 | 25953088 | |
568 | Ubiquitination | QKLSRGNYKVNQKSI HHHHCCCCCCCHHHH | 21.09 | 21890473 | |
576 | Acetylation | KVNQKSIKIAWALNK CCCHHHHHHHHHHHC | 33.20 | 25953088 | |
583 (in isoform 1) | Ubiquitination | - | 63.96 | 21890473 | |
583 (in isoform 2) | Ubiquitination | - | 63.96 | 21890473 | |
616 | Glutathionylation | PEELESFCEGGMLDS HHHHHHHHHCCCCCC | 7.08 | 22555962 | |
1078 | Acetylation | EKEEARGKEKPEVTD HHHHHCCCCCCCCCC | 57.94 | 26051181 | |
1080 | Acetylation | EEARGKEKPEVTDRA HHHCCCCCCCCCCCC | 50.38 | 25953088 | |
1091 | Acetylation | TDRAGGNKTVEPPIS CCCCCCCCCCCCCHH | 58.17 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SFR15_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SFR15_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SFR15_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SH3L1_HUMAN | SH3BGRL | physical | 22939629 | |
SVIL_HUMAN | SVIL | physical | 22939629 | |
UCRI_HUMAN | UQCRFS1 | physical | 22939629 | |
TXD17_HUMAN | TXNDC17 | physical | 22939629 | |
VINC_HUMAN | VCL | physical | 22939629 | |
VMA21_HUMAN | VMA21 | physical | 22939629 | |
SUCB2_HUMAN | SUCLG2 | physical | 22939629 | |
UPAR_HUMAN | PLAUR | physical | 22939629 | |
SPT2_HUMAN | SPTY2D1 | physical | 22939629 | |
VAPB_HUMAN | VAPB | physical | 22939629 | |
CDK12_HUMAN | CDK12 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-49, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-656 AND SER-1037, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154 AND THR-237, ANDMASS SPECTROMETRY. |